FMO5 and chronic granulomatous disease: PMNs from chronic granulomatous disease (CGD) patients (NADPH oxidase-deficient) or PMNs treated with DPI (NADPH oxidase inhibitor) exhibit delayed apoptosis in the presence of TNF-α and bacteria [4], [8], [36], [41].